Low-dose mirtazapine in treatment of major depression developed following severe nausea and vomiting during pregnancy: Two cases

General Hospital Psychiatry

Volumn 36, Issue 1, 2014, Pages 125.e5-125.e6

  Uguz, Faruk ^a  

^a NECMETTIN ERBAKAN UNIVERSITY   (Turkey)

Author keywords

Antidepressants; Mirtazapine; Pregnancy; Women

Indexed keywords

METOCLOPRAMIDE; MIRTAZAPINE;

ADULT; ANHEDONIA; ANXIETY; ARTICLE; CASE REPORT; CLINICAL GLOBAL IMPRESSION SCALE; DECREASED APPETITE; DISEASE ASSOCIATION; DISEASE SEVERITY; DOSE RESPONSE; DRUG DOSE INCREASE; DSM-IV; FEMALE; GESTATIONAL AGE; HAMILTON SCALE; HUMAN; INSOMNIA; LOW DRUG DOSE; MAJOR DEPRESSION; NAUSEA AND VOMITING; PREGNANCY OUTCOME; STRUCTURED INTERVIEW; TREATMENT RESPONSE; WEIGHT REDUCTION; YOUNG ADULT;

ANTIDEPRESSANTS; MIRTAZAPINE; PREGNANCY; WOMEN;

ADULT; ANTIDEPRESSIVE AGENTS, TRICYCLIC; DEPRESSIVE DISORDER, MAJOR; FEMALE; HUMANS; HYPEREMESIS GRAVIDARUM; MIANSERIN; PREGNANCY; PREGNANCY COMPLICATIONS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 85058720802     PISSN: 01638343     EISSN: 18737714     Source Type: Journal    
DOI: 10.1016/j.genhosppsych.2013.07.016     Document Type: Article

References (22)

1. Ismail S.K., Kenny L. Review on hyperemesis gravidarum. Best Pract Res Clin Gastroenterol 2007, 21:755-769.
2. Verberg M.F., Gillott D.J., Al-Fardan N., Grudzinskas J.G. Hyperemesis gravidarum, a literature review. Hum Reprod Update 2005, 11:527-539.
3. Munch S., Korst L.M., Hernandez G.D., Romero R., Goodwin T.M. Health-related quality of life in women with nausea and vomiting of pregnancy: the importance of psychosocial context. J Perinat 2011, 31:10-20.
4. Swallow B.L., Lindow S.W., Masson E.A., Hay D.M. Psychological health in early pregnancy: relationship with nausea and vomiting. J Obstet Gynecol 2004, 24:28-38.
5. Koken G., Yilmazer M., Cosar E., Sahin F.K., Cevrioglu S., Gecici O. Nausea and vomiting in early pregnancy: relationship with anxiety and depression. J Psychosom Obstet Gynecol 2008, 29:91-95.
6. Chou F.H., Lin L.L., Cooney A.T., Walker L.O., Riggs M.W. Psychosocial factors related to nausea, vomiting, and fatigue in early pregnancy. J Nurs Scholarsh 2003, 35:119-125.
7. Tan P.C., Vani S., Lim B.K., Omar S.Z. Anxiety and depression in hyperemesis gravidarum: prevalence, risk factors and correlation with clinical severity. Eur J Obstet Gynecol Reprod Biol 2010, 149:153-158.
8. Uguz F., Gezgin K., Kayhan F., Cicek E., Kantarci A.H. Is hyperemesis gravidarum associated with mood, anxiety and personality disorders: a case-control study. Gen Hosp Psychiatry 2012, 34:398-402.
9. Andrade S.E., Raebel M.A., Brown J., Lane K., Livingston J., Boudreau D., et al. Use of antidepressant medications during pregnancy: a multisite study. Am J Obstet Gynecol 2008, 198:194.e1-194.e5.
10. Watanabe N., Omori I.M., Nakagawa A., Cipriani A., Barbui C., McGuire H., et al. Safety reporting and adverse-event profile of mirtazapine described in randomized controlled trials in comparison with other classes of antidepressants in the acute-phase treatment of adults with depression: systematic review and meta-analysis. CNS Drugs 2010, 24:35-53.
11. Schwarzer V., Heep A., Gumbruch U., Rohde A. Treatment resistant hyperemesis gravidarum in a patient with type 1 diabetes mellitus: neonatal withdrawal symptoms after successful antiemetic therapy with mirtazapine. Arch Gynecol Obstet 2008, 277:67-69.
12. Guclu S., Gol M., Dogan E., Saygili U. Mirtazapine use in resistant hyperemesis gravidarum: report of three cases and review of the literature. Arch Gynecol Obstet 2005, 272:298-300.
13. Uguz F. Low-dose mirtazapine added to selective serotonin reuptake inhibitors in pregnant women with major depression or panic disorder including symptoms of severe nausea, insomnia and decreased appetite: three cases. J Matern Fetal Neonatal Med 2013, 26:1066-1068.
14. First M.B., Spitzer R.L., Gibbon M., Williams J.B.W. Structured clinical interview for DSM-IV clinical version (SCID-I/CV) 1997, American Psychiatric Press, Washington, DC.
15. Guy W. ECDEU assessment manual for psychopharmacology. US Department of Health, Education, Welfare publication (ADM) 76-338 1976, 218-222. National Institute of Mental Health, Rockville, MD.
16. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960, 23:56-62.
17. Gentile S. Drug treatment for mood disorders in pregnancy. Curr Opin Psychiatry 2011, 24:34-40.
18. Djulus J., Koren G., Einarson T.R., Wilton L., Shakir S., Diav-Citrin O., et al. Exposure to mirtazapine during pregnancy: a prospective, comparative study of birth outcomes. J Clin Psychiatry 2006, 67:1280-1284.
19. ACOG Practice Bulltein Use of psychiatric medications during pregnancy and lactation. Obstet Gynecol 2008, 111:1001-1020.
20. Lozano R. Mirtazapine and ondansetron: a dual pharmacodynamic and pharmacokinetic interaction. Afr J Psychiatry 2013, 16:55-56.
21. Anttila S.A., Leinonen E.V. A review of the pharmacological and clinical profile of mirtazapine. CNS Drug Rev 2001, 7:249-264.
22. Chang F.L., Ho S.T., Sheen M.J. Efficacy of mirtazapine in preventing intrathecal morphine-induced nausea and vomiting after orthopaedic surgery. Anaesthesia 2010, 65:1206-1211.